Navigation Links
Anthrax Monoclonal Antibody Valortim Demonstrates Therapeutic,Effect in New Primate Model of Established Anthrax Infection

imilar potency for neutralizing anthrax toxin in vitro as was seen with serum obtained from subjects who had been vaccinated with anthrax vaccine.

About Anthrax

According to the Centers for Disease Control and Prevention, anthrax is an acute infectious disease caused by the spore-forming bacterium Bacillus anthracis. Anthrax most commonly occurs in hoofed mammals and can also infect humans. Symptoms of disease vary depending on how the disease was contracted, but usually occur within seven days after exposure. The serious forms of human anthrax are inhalation anthrax, cutaneous anthrax, and intestinal anthrax. Initial symptoms of inhalation anthrax infection may resemble a common cold. After several days, the symptoms may progress to severe breathing problems and shock. Inhalation anthrax is often fatal, even with the use of antibiotics.

About PharmAthene, Inc.

PharmAthene, a privately-held biotechnology company, was formed to meet the critical needs of the United States by developing biodefense products. PharmAthene is dedicated to the rapid development of important and novel biotherapeutics to address biological pathogens and chemicals that may be used as weapons of bioterror. PharmAthene's lead programs include Valortim(TM) for the prevention and treatment of anthrax infection and Protexia(R) for the prevention and treatment of morbidity and mortality associated with exposure to chemical nerve agents. For more information on PharmAthene, please visit www.PharmAthene.com.

About Medarex, Inc.

Medarex is a biopharmaceutical company focused on the discovery, development and potential commercialization of fully human antibody-based therapeutics to treat life-threatening and debilitating diseases, including cancer, inflammation, autoimmune disorders and infectious diseases. Medarex applies its UltiMAb(R) technology and product development and clinical manufacturing exper
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Targanta Study Shows Oritavancin Treatment Effective in a Mouse Model of Anthrax
2. Cethromycin Shown Effective Against Anthrax in Study
3. Anthrax Monoclonal Antibody Valortim(tm) Demonstrates Therapeutic Effect in New Primate Model of Established Anthrax Infection
4. Phase I Results for ImClone Pipeline Anti-IGF-1R Monoclonal Antibody IMC-A12 Presented at ASCO
5. Vicals Vaxfectin Adjuvant With Needle-free Delivery Enhances DNA Vaccine Performance; Yields Antibody Responses Comparable to Electroporation Without Tolerability Issues
6. Positive Results Using Affitech-Identified Human Antibody That Blocks VEGF Binding to VEGF Receptor 2 in Preclinical Cancer Model Reported by Peregrine
7. Seattle Genetics Highlights Data on its Proprietary Antibody-Drug Conjugate Technology at AACR
8. Medarex Presents Preclinical Data Demonstrating Potent Anti-Tumor Activity of Anti-CD19 and Anti-CD70 Antibody-Drug Conjugates in Cancer Animal Models
9. Cell Genesys Reports GVAX Immunotherapy for Prostate Cancer Induces a Broad, Patient-Specific Antibody Response
10. Mymetics HIV Vaccine Achieves Research Breakthrough, Eliciting Protective Antibody Response in Mucosal Tissues of Non-Human Primate Model
11. La Jolla Pharmaceutical Provides Update on Interim Antibody Results From Riquent Lupus Phase 3 Trial

Post Your Comments:
(Date:11/9/2009)...LEN ROCK, Pa., Nov. 9 ARmark Authe...nounced today an alliance in the development and i...an authentication technology that incorporates mic...ase film coatings of solid oral dosage forms (SODF...s Colorcon exclusive rights to market ARmark,s mic...
(Date:11/9/2009)...LISO VIEJO, Calif., Nov. 9 /PRNewswire-FirstCall/ ...nology and services resource for pathologists, onc...nounced that it is scheduled to make presentations...City. ,, The first presentation will be made at...e Conference at 1:40 pm EST on Tuesday, November 1...
(Date:11/6/2009)...OTHELL, Wash., Nov. 6 SC...ncial results for the three and nine months ended ...LR Pharma,s President and CEO, said, "We continue ...-hour ibuprofen formulation. Several potential par..., personnel and external resources as they evaluat...
Breaking Medicine Technology:ARmark Authentication Technologies, LLC and Colorcon, Inc. Announce Alliance 2ARmark Authentication Technologies, LLC and Colorcon, Inc. Announce Alliance 3Clarient to Present at Upcoming Healthcare Investor Conferences in New York City 2SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 2SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 3SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 4SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 5SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 6SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 7SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 8SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 9Recently Released Data from the National Survey of Childrens Health Reports That Autism Now Affects 1 25 of Children and is More Common Than Childrens 53454 1Recently Released Data from the National Survey of Childrens Health Reports That Autism Now Affects 1 25 of Children and is More Common Than Childrens 53454 2Locum Leaders Taps Hospitalist as Chief Medical Officer 3B Strengthens Leadership in Hospital Medicine Recruitment and Job Placement 53452 1Locum Leaders Taps Hospitalist as Chief Medical Officer 3B Strengthens Leadership in Hospital Medicine Recruitment and Job Placement 53452 2Patients Issue Summer Call to Action 3A We Need You to Donate Blood NOW 53450 1Patients Issue Summer Call to Action 3A We Need You to Donate Blood NOW 53450 2Patients Issue Summer Call to Action 3A We Need You to Donate Blood NOW 53450 3
...euticals,Inc. (OTCBB: ORMP.OB) ( http://www.oramed...unced today that it has been selected to present t...tudy to Assess the Safety,Pharmacokinetics (PK) an...ns,in Subjects with Type 2 Diabetes (T2DM)" at the...n,s Scientific Sessions Conference in New Orleans....
... New England Journal of Medicine , , ALEXAN...y published online today in the New England Journ...ose (sugar) control for critical care patients wit...ove outcomes and is associated with an increase in...-bin/prnh/20090324/DC88061LOGO-a ) , (Logo: http...
Other Medicine Technology:Oramed Pharmaceuticals to Present Oral Insulin Phase 2A Trial Results at the Upcoming Annual Meeting of the ADA (June 5-9, New Orleans, LA) 2Joint Statement from the American Diabetes Association and American Association of Clinical Endocrinologists on the NICE-SUGAR Study on Intensive Versus Conventional Glucose Control in Critically Ill Patients 2Joint Statement from the American Diabetes Association and American Association of Clinical Endocrinologists on the NICE-SUGAR Study on Intensive Versus Conventional Glucose Control in Critically Ill Patients 3Joint Statement from the American Diabetes Association and American Association of Clinical Endocrinologists on the NICE-SUGAR Study on Intensive Versus Conventional Glucose Control in Critically Ill Patients 4
(Date:11/9/2009)...ire-USNewswire/ -- New Mayo Clinic research has fo...dramatically reduces patient hospital stay and rec...s week at the North Central Section of the America..., (Logo: http://www.newscom.com/cgi-bin/prnh/20...l audio and video resources, including excerpts fr...
(Date:11/9/2009)...wire/ -- At a time when the 250,000+ eligible Medi...d about finding affordable health insurance, they ..., The Today,s Options® Preferred Provider ...s a cost-effective and comprehensive alternative t... People with Medicare can choose to sign up for t...
(Date:11/9/2009)... our current campaign finance system ,, WASHIN... Congress who noted "no" on health care reform leg...llion more in campaign donations from health insur...e legislation to overhaul of the nation,s health c...alition of campaign reform groups. ,, "The heal...
(Date:11/9/2009)... , , WHAT: All PETCO stores nationwide will...facilitated by specially trained in-store nutritio...t 2 p.m. During the 30-minute, works...needs of, their dogs and cats, have a...ood pet nutrition, receive an assessment of their ...
(Date:11/9/2009)... and the University of Florida Proton Therapy Inst...n therapy for St. Jude patients. The announcement ...o evaluate the use of proton therapy for rare brai..., Under the clinical protocol, St. Jude will ref...oton Therapy Institute in Jacksonville, Fla. The p...
Breaking Medicine News(10 mins):Health News:Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits 2Health News:Mayo Researchers Find Robotic Repair for Vaginal Prolapse Has Significant Benefits 3Health News:Maine Residents With Medicare Searching for Affordable and Innovative Insurance Have Competitive Medicare Advantage Option 2Health News:'No' Votes on Health Care Bill Received $2.3 Million More from Health Insurance Industry 2Health News:St. Jude and UF Proton Therapy Institute to begin proton therapy clinical trial 2
...h system of southern Australian hospitals has been... their elective surgery admissions //and waiting t...he public hospitals in the state having recorded t...h Minister Tony Abbott, who released a report on t...
... of a 65-year-old woman at the Heatherside Hospita...omber died //from asphyxiation after she apparentl.... The HSE said, it is fully co-operating with t...are facility in Cork. The HSE added that the hospi...
...rian Burden of Disease reports that the Central Go...h of its men and women//. The study was conducted ...dy the frequently occurring diseases and injuries ...bourne is reported to be in the pink of health but...
...tive study, which involved hospitalized men volunt...owed lesser urinary tract //infectious risk than t...t reduction in urinary tract infections were found...en whose urine was collected with an external or '...
...niversity scientists have discovered a method to c...esult in curbing the spread of cancer//. This, if ...fe to cancer patients. According to the scien... The researchers said “By blocking the blood su...
...a dengue outbreak in Kolkata have come true with t...orted from a southern //neighbourhood. A you...ght from the disease at the Nilratan Medical Colle...e city's civic authorities, Kolkata Municipal Corp...
Other Medicine News:Health News:South Australian health System In The Bottom Of Rankings 2Health News:External Catheters Linked with decreased UTI Risk in Men 2Health News:External Catheters Linked with decreased UTI Risk in Men 3Health News:External Catheters Linked with decreased UTI Risk in Men 4
VitalWorks Intuition PM Ophthalmology
...ITER Electronic Medical Records (including ExamDRA... record instrument in the industry. Doctors and st...effortless speed and accuracy using our trademarke...ed for typing, we have created the fastest, easies...
Simplex™ P Bone Cement
...1 Gentamicin Bone Cement, a high viscosity antibio...ional market for over a decade, eliminates the inc...e premixed powder helps to prevent inconsistency i...cin Bone Cement provides the same proven character...
Medicine Products: